Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2003
12/04/2003WO2003100074A2 Animal genotyping method
12/04/2003WO2003100064A1 Novel ubiquitin ligase
12/04/2003WO2003100057A1 Chemical sensor system
12/04/2003WO2003100041A1 Cd100 semaphorin in myelination
12/04/2003WO2003100033A2 ANTI-αvβ6 ANTIBODIES
12/04/2003WO2003100028A2 Tr2, tr4, tr2/tr4 double knockouts and uses thereof
12/04/2003WO2003100024A2 Treatment for diabetes
12/04/2003WO2003100012A2 Microarrays and method for running hybridization reaction for multiple samples on a single microarray
12/04/2003WO2003100006A2 Method of improved prostate cancer detection
12/04/2003WO2003100002A2 Predicting the significance of single nucleotide polymorphisms (snps) using ensemble-based structural energetics
12/04/2003WO2003099997A2 Methods and compositions for regulation and manipulation of steroidogenesis
12/04/2003WO2003099996A2 Detection of secreted polypeptides
12/04/2003WO2003099995A2 Murine ortholog of the human disrupted-in-schizophrenia 1 gene
12/04/2003WO2003099994A2 Method of detecting cholesterol transporting proteins
12/04/2003WO2003099957A1 Rnp immunoprecipitation assay
12/04/2003WO2003099869A1 Antibody capable of recognizing 8-nitroguanine
12/04/2003WO2003099868A2 Method for obtaining anti-idiotype antibodies
12/04/2003WO2003099864A1 Use of monocarboxylate transporter protein for thyroid hormone transport
12/04/2003WO2003099802A1 POLYMERIC AMMONIUM AND OR PHOSPHONIUM SALTS HAVING ADDED π-ELECTRONS AND HIGHER MOLECULAR WEIGHT AS ENHANCERS FOR CHEMILUMINESCENT SYSTEMS
12/04/2003WO2003099783A2 Tropane compounds
12/04/2003WO2003099781A2 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES
12/04/2003WO2003099779A2 Hemipteran muscarinic receptor
12/04/2003WO2003099778A2 Inhibitors of proteins from the rho-gef family
12/04/2003WO2003099412A1 Apparatus and method for separating and concentrating fluids containing multiple components
12/04/2003WO2003099340A1 Novel chimeric cd154
12/04/2003WO2003099328A1 Methods and materials for treating inflammatory conditions
12/04/2003WO2003099318A2 Pancreas-specific proteins
12/04/2003WO2003099313A1 Low molecular weight protein tyrosine phosphatase (lmw-ptp) as a diagnostic and therapeutic target
12/04/2003WO2003099312A1 Method for determining immune system affecting compounds
12/04/2003WO2003099289A2 Compositions and their uses for alleviating pain
12/04/2003WO2003099229A2 Functional protein expression for rapid cell-free phenotyping
12/04/2003WO2003099222A2 Pseudo-tissues and uses thereof
12/04/2003WO2003099210A2 Methods of modulating tubulin deacetylase activity
12/04/2003WO2003099209A2 Compositions and methods for screening and identifying anti-hcv agents
12/04/2003WO2003099201A2 Compositions and methods of use for a fibroblast growth factor
12/04/2003WO2003099199A2 Compositions and methods for promoting or inhibiting angiogenesis
12/04/2003WO2003099190A2 Serum transfer cup
12/04/2003WO2003099107A2 Methods and kits for the detection of renal cell carcinoma in a biological fluid of a patient
12/04/2003WO2003099105A2 Diagnosis and treatment of human dormancy syndrome
12/04/2003WO2003099104A2 Elisa assay of serum soluble cd22 to assess tumor burden/relapse in subjects with leukemia and lymphoma
12/04/2003WO2003090605A3 Method and system for the detection of cardiac risk factors
12/04/2003WO2003089896A3 Rapid assay, method and system for detecting biowarfare agents
12/04/2003WO2003087356A3 Helicokinin-receptor from insects
12/04/2003WO2003083431A3 Pressure activated calibration system for chemical sensors
12/04/2003WO2003083041A3 Cripto-specific antibodies
12/04/2003WO2003079011A3 Method for quantitatively determining a number of analytes
12/04/2003WO2003076936A9 Method of preparing a protein array based on biochemical protein-protein interaction
12/04/2003WO2003075838A3 Methods and compositions for pharmacological and toxicological evaluation of test agents
12/04/2003WO2003074548A3 Phage ligand sensor devices and uses thereof
12/04/2003WO2003073075A3 Method for the analysis of lubricant basicity
12/04/2003WO2003072747A8 COMPARATIVE MOLECULAR FIELD ANALYSIS (CoMFA) UTILIZING TOPOMERIC ALIGNMENT OF MOLECULAR FRAGMENTS
12/04/2003WO2003070981A3 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines
12/04/2003WO2003070891A3 Method of determining adenovirus particle concentration
12/04/2003WO2003068201A3 High affinity antibody having a tcr-like specificity and use in detection and treatment
12/04/2003WO2003064460A8 Two gonadotropin releasing hormones and a method to isolate the same
12/04/2003WO2003063679A3 Hepatitis e virus clones and methods of their use
12/04/2003WO2003062867A3 Methods and apparatus for generating and utilizing linear moving optical gradients
12/04/2003WO2003060468A3 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease
12/04/2003WO2003060161A3 A method for assessing the potential responsiveness of a subject to anti-cancer drugs affecting the ras signal transduction pathway
12/04/2003WO2003059290A3 Diagnostic and therapeutic uses of topors
12/04/2003WO2003059285A3 Rip2: a method of signaling in the innate and adaptive immune systems
12/04/2003WO2003058192A3 System and method for differentiating between cells with normal and pathologically altered cytoskeleton
12/04/2003WO2003057179A3 Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
12/04/2003WO2003057170A3 Oral insulin therapy
12/04/2003WO2003057168A3 Cancer-associated epitope
12/04/2003WO2003055448A3 Antifungal compositions
12/04/2003WO2003054158A3 Rapidly maturing fluorescent proteins and methods for using the same
12/04/2003WO2003054011A3 Polymorphisms of the octn1 and octn2 cation transporters associated with inflammatory bowel disease
12/04/2003WO2003050499A3 Use of a labeled ligand having human cd4 specificity
12/04/2003WO2003049671A3 Functionalized materials and libraries thereof
12/04/2003WO2003047509A3 Enzyme activity profiles
12/04/2003WO2003046684A3 Methods of data analysis using ranks
12/04/2003WO2003046552A3 Screening method for compounds that modulate neuronal activity
12/04/2003WO2003045910A3 Diagnosis of endothelial dysfunction by nitric oxide bioactivity index
12/04/2003WO2003044225A3 Profiling of the immune gene repertoire
12/04/2003WO2003042658A3 Methods and compositions for enhancing detection in determinations employing cleavable electrophoretic tag reagents
12/04/2003WO2003040725A3 Method of determining whether a patient afflicted with cancer can be treated by a therapeutic agent that targets the 17-1a antigen
12/04/2003WO2003038404A3 In vitro metabolic engineering on microscale devices
12/04/2003WO2003035894A3 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
12/04/2003WO2003035832A3 CTSLS AS MODIFIERS OF THE p53 AND Apaf-1 PATHWAYS AND METHODS OF USE
12/04/2003WO2003032291A3 Method and device for performing automated, industrial analysis and/or classification of foodstuffs, and foodstuffs
12/04/2003WO2003031947A3 Device for sequencing nucleic acid molecules
12/04/2003WO2003031462A3 Nogo receptor-mediated blockade of axonal growth
12/04/2003WO2003028537A3 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
12/04/2003WO2003026590A3 Biological control of nanoparticles
12/04/2003WO2003026398A3 V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto
12/04/2003WO2003025579A3 Use of heart fatty acid binding protein
12/04/2003WO2003024405A3 Methods and compositions for inhibiting the proliferation of prostate cancer cells
12/04/2003WO2003022879A3 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them
12/04/2003WO2003022435A3 Sample vessels
12/04/2003WO2003021273A3 Diagnosis of carcinomas
12/04/2003WO2003020901A3 Compositions and methods relating to prostate specific genes and proteins
12/04/2003WO2003018798A3 G-protein coupled receptor and dna sequences thereof
12/04/2003WO2003018755A3 Wild-type ras as a cancer therapeutic agent
12/04/2003WO2003016900A3 Method and system for determining the type of fuel used to power a vehicle
12/04/2003WO2003016560A3 Methods for diagnosing and treating neoplasias using nf-at transcription factors
12/04/2003WO2003016491A3 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
12/04/2003WO2003014328A3 Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
12/04/2003WO2003014145A3 Peptides that bind to atherosclerotic lesions
12/04/2003WO2003012043A3 Enhancing organ maturity in neonates and predicting their duration of intensive care
1 ... 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 ... 3937